Journal
THORAX
Volume 73, Issue 10, Pages 926-935Publisher
BMJ PUBLISHING GROUP
DOI: 10.1136/thoraxjnl-2017-211073
Keywords
-
Categories
Funding
- National Institute of Health Research (UK)
- European Society of Intensive Care Medicine
- Guy's & St Thomas' and King's College London NIHR Comprehensive Biomedical Research Centre (BRC)
- Whittington Hospital NHS Trust
- Research Councils UK
- NIHR Clinical Research Facility
- BRC at Guy's and St Thomas' NHS Foundation Trust (GSTT)
- King's College London
- University College London
- UCLH BRC
- National Institute for Health Research (NIHR) Biomedical Research Centre based at Imperial College Healthcare NHS Trust
- Imperial College London
- Wellcome Trust
- Merz Pharmaceuticals
- MRC [G1001362, G0501985] Funding Source: UKRI
Ask authors/readers for more resources
Objectives To characterise the sketetal muscle metabolic phenotype during early critical illness. Methods Vastus lateralis muscle biopsies and serum samples (days 1 and 7) were obtained from 63 intensive care patients (59% male, 54.7 +/- 18.0 years, Acute Physiology and Chronic Health Evaluation II score 23.5 +/- 6.5). Measurements and main results From day 1 to 7, there was a reduction in mitochondrial beta-oxidation enzyme concentrations, mitochondrial biogenesis markers (PGC1 alpha messenger mRNA expression (-27.4CN (95% CI -123.9 to 14.3); n=23; p=0.025) and mitochondria' DNA copy number (-1859CN (IQR -5557-1325); n=35; p=0.032). Intramuscular ATP content was reduced compared tocompared with controls on day 1 (17.7mmol/kg/dry weight (dw) (95% CI 15.3 to 20.0) vs. 21.7 mmol/kg Idw (95% CI 20.4 to 22.9); p<0.001) and decreased over 7 days (-4.8 mmol/kg dw (IQR 8.0-1.2); n=33; p=0.001). In addition, the ratio of phosphorylated:total AMP-K (the hioenergetic sensor) increased (0.52 (IQR 0.09-2.6); n=31; p<0.001). There was an increase in intramuscular phosphocholine (847.2AU (IQR 232.5-1672); n=15; p=0.022), intramuscular tumour necrosis factor receptor 1 (0.66 pg (IQR -0.44-3.33); n=29; p=0.041) and IL-10 (13.6 ng (IQR 3.4-39.0); n=29; p=0.004). Serum adiponectin (10.3 mu g (95% CI 6.8 to 13.7); p<0.001) and ghrelin (16.0 ng/mL (IQR 7-100); p=0.028) increased. Network analysis revealed a close and direct relationship between bioenergetic impairment and reduction in muscle mass and between intramuscular inflammation and impaired anabolic signaling. ATP content and muscle mass were unrelated to lipids delivered. Conclusions Decreased mitochondrial biogenesis and dysregulated lipid oxidation contribute to compromised skeletal muscle hioenergetic status. In addition, intramuscular inflammation was associated with impaired anabolic recovery with lipid delivery observed as bioenergetically inert. Future clinical work will focus on these key areas to ameliorate acute skeletal muscle wasting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available